Buy Alert: 2 Marijuana Stocks That Could Double Your Investment In 2021

If you expect cannabis stocks to stage a turnaround in 2021, you can look to invest in these two marijuana heavyweights.

| More on:

For the last decade, big tech has dominated discussions within the investment community, and for good reason. Shares of Apple, Facebook, Amazon, Microsoft, and Alphabet have easily crushed the broader markets since the financial crisis of 2008-09.

Even amid the pandemic, these tech heavyweights are primarily responsible for the market recovery since March 2020. The big tech companies were expected to grow at an enviable rate and they have not disappointed investors.

However, when it comes to investing in growth stocks, cannabis companies are not far behind. The marijuana industry has been hit by valuation concerns, high tax rates, low profitability, and a slew of other structural issues in the last two years. But there is a good chance that the pot stocks have bottomed out and may move higher in 2021.

Here we look at two such cannabis giants that can easily double your money in 2021.

Green Thumb Industries

The first cannabis company on the list is Green Thumb Industries (CNSX:GTII), a multistate operator in the U.S. Green Thumb has 49 operational dispensaries in 12 states south of the border. It has focused its expansion efforts in its home state of Illinois, which legalized recreational cannabis in January 2020.

Shares of Green Thumb Industries have returned 69% in 2020 and are well poised to move higher in 2021 and beyond. The company’s huge presence in Illinois and its growing market share in the tourist-heavy state of Nevada will be the primary drivers of top-line growth.

These two states might also generate US$1 billion in annual sales by 2024 which means Green Thumb’s growth story remains intact. Green Thumb generates over 65% of sales from higher-margin derivatives products, allowing the firm to consistently post a positive EBITDA and net income at a time when peers are burning cash at an alarming rate.

Charlotte’s Web Holdings

Charlotte’s Web Holdings (TSX:CWEB) investors have lost over 50% year-to-date. The stock has in fact lost 86% in market value since August 2019. In the June quarter, Charlotte’s sales were down 13.6% year-over-year at US$21.6 million. Its DTC or online sales accounted for 72% of sales and rose by a healthy 33.6% year-over-year. However, the company’s lower in-store sales and foot traffic due to the pandemic resulted in a revenue decline for the June quarter.

Another matter of concern for investors was Charlotte’s widening losses that stood at US$14.4 million in Q2 compared to a net income of US$2.2 million in the prior-year period. The company’s administrative expenses were in fact as much as its revenue which has contributed to the stock’s less than impressive performance in 2020.

However, Charlotte’s expects revenue growth to gain pace in the second half of 2020 as customers return to stores, resulting in higher traffic. Further, the shift in shopping trends will continue to increase its DTC sales in the next several quarters.

Charlotte’s reported a healthy gross margin of 64.8% in Q2m which means it has enough room to focus on cost optimization and improve the bottom line. Analysts tracking the stock expect sales to increase by just 3.1% to US$97.5 million in 2020.

However, Wall Street expects sales to touch $146 million in 2021, which will also increase its adjusted net income to $0.04 per share, compared to a net loss of $0.3 per share in 2020.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. David Gardner owns shares of Alphabet (A shares), Alphabet (C shares), Amazon, Apple, and Facebook. Tom Gardner owns shares of Alphabet (A shares), Alphabet (C shares), and Facebook. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Amazon, Apple, Charlottes Web Holdings, Facebook, and Microsoft and recommends the following options: long January 2022 $1920 calls on Amazon, long January 2021 $85 calls on Microsoft, short January 2021 $115 calls on Microsoft, and short January 2022 $1940 calls on Amazon. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »